Crypto News

2 hours ago

Theriva Biologics (TOVX) Stock Soars 63% on Promising Pancreatic Cancer Trial Results

Stocks

Theriva Biologics (TOVX) stock surged 63% after Phase 2b trial data revealed VCN-01 plus chemo improved survival in metastatic pancreatic cancer patients.

The post Theriva Biologics (TOVX) Stock Soars 63% on Promising Pancreatic Cancer Trial Results appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$ADA$ARB$BITF$BLSH$BMNR$BONK$CLAW Token Scam$DBKSF$ENA$JENNER Token$LUXFF$MATH$MTT token$NIGHT$PUMP$RAY$S$SEA$SOL$SPACE token

Latest News